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Purpose: To describe the clinical and genetic findings in one Chinese family with autosomal recessive retinitis pigmentosa
(arRP) and in three unrelated Chinese families with Usher syndrome type II (USH2).
Methods: One family (FR1) with arRP and three unrelated families (F6, F7, and F8) with Usher syndrome (USH),
including eight affected members and seven unaffected family individuals were examined clinically. The study included
100 normal Chinese individuals as normal controls. After obtaining informed consent, peripheral blood samples from all
participants were collected and genomic DNA was extracted. Genotyping and haplotyping analyses were performed on
the known genetic loci for arRP with a panel of polymorphic markers in family FR1. In all four families, the coding region
(exons 2–72), including the intron-exon boundary of the USH2A (Usher syndrome type −2A protein) gene, was screened
by PCR and direct DNA sequencing. Whenever substitutions were identified in a patient, a restriction fragment length
polymorphism (RFLP) analysis, single strand conformation polymorphism (SSCP) analysis, or high resolution melt curve
analysis (HRM) was performed on all available family members and on the 100 normal controls.
Results: The affected individuals presented with typical fundus features of retinitis pigmentosa (RP), including narrowing
of the vessels, bone-spicule pigmentation, and waxy optic discs. The electroretinogram (ERG) wave amplitudes of the
available probands were undetectable. Audiometric tests in the affected individuals in family FR1 were normal, while
indicating moderate to severe sensorineural hearing impairment in the affected individuals in families F6, F7, and F8.
Vestibular function was normal in all patients from all four families. The disease-causing gene in family FR1 was mapped
to the USH2A locus on chromosome 1q41. Seven novel mutations (two missenses, one 7-bp deletion, two small deletions,
and two nonsenses) were detected in the four families after sequencing analysis of USH2A.
Conclusions: The results further support that mutations of USH2A are also responsible for non-syndromic RP. The
mutation spectrum among Chinese patients might differ from that among European Caucasians.
Retinitis pigmentosa (RP) is a heterogeneous group of
retinal dystrophies, characterized by progressive degeneration
of the photoreceptors. Clinical features include progressive
night blindness, constriction and gradual loss of the peripheral
visual  field,  and  eventual  loss  of  visual  acuity.  With  an
incidence of 1 in 3,500, RP can be inherited as an autosomal
recessive (arRP), an autosomal dominant (adRP), or an X-
linked recessive (xlRP) pattern [1,2].
RP can be classified as syndromic and nonsyndromic RP,
based  on  whether  or  not  extra-ocular  diseases  exist.
Nonsyndromic  arRP  is  caused  by  the  mutations  of  32
identified genes [1,2]. Syndromic RP includes more than 30
different syndromes [1,2]. The most common syndrome is
Usher syndrome (USH), which is also an autosomal recessive
disorder characterized by sensorineural hearing loss, variable
vestibular dysfunction, and visual impairment due to retinitis
pigmentosa [2,3]. Clinically, USH is subdivided into three
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types: USH type I (USH1), USH type II (USH2), and USH
type III (USH3). USH1 is the most severe form of this disease
and  is  characterized  by  congenital  profound  hearing  loss,
prepuberal onset of RP, and vestibular dysfunction. Patients
with USH2 experience congenital moderate to severe hearing
impairment, and postpuberal onset of RP with intact vestibular
function. Patients with USH3 show progressive postlingual
hearing  loss,  later  onset  of  RP,  and  variable  vestibular
dysfunction.  Of  the  three  clinical  types,  USH2,  which
accounts for more than half of all patients with USH, is the
most common form of USH [2-4]. To date, reports indicate
that three genes (USH2A [Usher syndrome type −2A protein],
GPR98  [G-protein  coupled  receptor  98],  and  DFNB31
[CASK-interacting protein CIP98 isoform 1]) are responsible
for  USH2,  and  most  USH2  patients  have  mutations  in
USH2A [3-9].
USH2A,  located  on  chromosome  1q41,  has  two
alternatively  spliced  isoforms:  a  short  USH2A  isoform  a,
consisting  of  21  exons,  and  a  long  USH2A  isoform  b,
consisting of 51 additional exons at the 3′ end of USH2A [5,
9]. The protein usherin, encoded by USH2A isoform b, is a
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1539transmembrane protein, which has 5,202 amino acids [9]. The
usherin is transiently expressed in the stereocilia of cochlear
hair cells, suggesting an important role in their maturation
[4,9-11].  In  mammalian  photoreceptors,  the  usherin  is
expressed specifically in the connecting cilia, which links the
inner and outer retinal segments; this would appear to indicate
that  it  is  crucial  for  the  long-term  maintenance  of
photoreceptors [9-11].
Since  identification  of  USH2A,  several  studies  have
indicated that mutations of this gene can cause a significant
proportion of non-syndromic recessive RP [12-20].
This  study  investigated  a  Chinese  family  with  non-
syndromic  arRP.  After  haplotyping  analysis,  the  disease-
causing gene was mapped to the USH2A region. Mutations
screening of the USH2A gene, corresponding to the USH2A
isoform  b,  was  then  performed  in  this  nonsyndromic  RP
family and in three USH2 families. Seven novel mutations
were identified.
METHODS
Clinical data and sample collection: This study adhered to the
tenets of the Declaration of Helsinki for research involving
human  subjects.  The  Beijing  Tongren  Hospital  Joint
Committee on Clinical Investigation approved the study. One
Chinese family with nonsyndromic RP and three unrelated
Chinese families with USH were referred to Beijing Tongren
Hospital.  After  informed  consent  was  obtained,  each
participant underwent careful ophthalmologic examinations,
including best-corrected visual acuity testing using E decimal
charts,  slit-lamp  biomicroscopy,  fundus  examination  with
dilated  pupils,  visual  field  testing,  and  electroretinogram
(ERG) examination. Three probands from the three families
TABLE 2. PRIMERS USED IN SINGLE STRAND CONFORMATION POLYMORPHISM (SSCP), HIGH RESOLUTION MELT CURVE ANALYSIS
(HRM), AND PAGE (PAGE) ANALYSIS IN THIS STUDY.
Primer Sequence (5′-3′)
U11 SSCP F: TGATGCAGGAAGGAACTGTG
U11 SSCP R: CCTGGCAAATGCAGTCTTC
U32 HRM F: ATCCCTTCCCAGTTCTTTG
U32 HRM R: CAGATATGGAACCCCTGGAT
U38 SSCP F: AATTGGCCAGGTCAACTCAG
U38 SSCP R: GCACCCAAAGGTTTGTCTC
U48 PAGE F: TGGTATCCATGCGCTAAAAC
U48 PAGE R: CACTTGGAGTCTTGAGTGAGAA
          Abbreviations: U represents USH2A; the number represents the name of the exon; F represents forward; R represents reverse.
Figure  1.  The  pedigrees  of  the  four
Chinese  families  with  autosomal
recessive retinitis pigmentosa (arRP) or
Usher syndrome type II (USH2), and
with  mutations  in  the  USH2A  gene.
Pedigree  and  haplotyping  analyses  of
family one (FR1) showed segregation
with  six  microsatellite  markers  on
chromosome  1  listed  in  descending
order from the centromeric end. Squares
indicate males; circles indicate females;
slashed  symbols  indicate  deceased;
solid  symbols  indicate  affected;  open
symbols indicate unaffected; and arrow
symbol  indicates  proband.  The
genotype of each evaluated individual is
shown below the individual’s symbol
and  identification  number.
Abbreviations:  Wild  type  (W);
p.C934W (M1); p. W2744C (M2); p.
R626X  (M3);  p.  I2084fs  (M4);  p.
W1263X  (M5);  p.  D3165fs(M6);
p.G2375fs (M7); p.Y4801X (M8).
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1540with USH underwent audiometric testing, including otoscopy
and standard pure-tone audiometry, and vestibular tests. The
patients  with  nonsyndromic  arRP  were  given  audiometric
tests after the disease gene was mapped to chromosome 1q41,
where the USH2A gene is located. Clinical diagnosis of USH2
was  based  on  the  clinical  history,  typical  RP  fundus
appearance,  sensorineural  hearing  impairment,  and  intact
vestibular  function.  Peripheral  blood  was  obtained  by
venipuncture, and genomic DNA was extracted according to
standard phenol protocols.
Genotyping  and  haplotyping  analysis:  Genotyping  was
performed with 50 microsatellite markers from autosomes for
the  known  arRP  loci  in  family  FR1  (Appendix  1).  Then,
genotyping  and  haplotyping  analysis  was  performed  with
another  six  microsatellite  markers  -  D1S237,  D1S419,
D1S556,  D1S229,  D1S227,  and  D1S2860  -  around  the
USH2A  gene.  The  fine  mapping  primer  sequences  were
obtained from the Human Genome Database (GDB). Pedigree
and haplotype maps were constructed using Cyrillic V. 2.0
software.
Mutation screening of the USH2A gene: Mutation screening
was performed in all four families using direct DNA sequence
analysis. The coding region (exons 2–72) and the exon-intron
boundaries of USH2A were amplified by PCR in the probands
of the four families. The pairs of primers for exons 2–72 were
used according to previously published (Table 1) articles [5,
9,21].  For  direct  sequencing,  amplicons  were  purified
(Shenneng Bocai PCR purification kit; Shenneng, Shanghai,
China). An automatic fluorescence DNA sequencer (ABI,
Prism 373A; Perkin Elmer, Foster City, CA), used according
to  the  manufacturer’s  instructions,  sequenced  the  purified
PCR products in both the forward and reverse directions.
Nucleotide  sequences  were  compared  with  the  published
cDNA  sequence  of  the  USH2A  gene  (GenBank
NM_206933.2).  For  USH2A,  cDNA  numbering  +1
corresponds to A in the ATG translation initiation codon in
RefSeq (AY481573.1).
Restriction  fragment  length  polymorphism  analysis:
Variations  (c.2802T>G,  c.8232G>C,  c.3788G>A,  and  c.
14403C>G) found in the sequencing were confirmed with the
restriction endonucleases Hinc II (TaKaRa, Dalian, China),
HpyCH4V, BsaI, and SpeI (New England Biolabs, Ipswich,
MA), respectively, which were used in all available family
members and in the100 normal controls.
Single strand conformation polymorphism: To validate the
variations  (c.  1876C>T  and  c.7123delG)  found  in  the
sequencing,  a  single  strand  conformation  polymorphism
(SSCP)  analysis  was  performed  in  all  available  family
members  and  in  the  100  normal  controls.  As  the  PCR
fragments used in SSCP analysis were between 150 and 300
bp, two pairs of specific primers were designed for detecting
mutations in exon 11 and exon 38 (Table 2).
High-resolution melt curve analysis: To confirm the variation
(c.6249delT) found in the sequencing, a high-resolution melt
curve analysis (HRM) was performed in the available family
members and in the 100 normal controls. Primer sequences
Figure 2. The appearance of the fundus
in  two  patients  with  non-syndromic
retinitis  pigmentosa  (RP)  or  Usher
syndrome type II (USH2). A: Fundus
appearance  of  patient  077066  from
family one (FR1), shows typical retinal
degeneration  with  attenuation  of  the
retinal  vessels,  irregular  pigment
clumps in the retina, and waxy pallor of
the  optic  nerve  head.  B:  Fundus
appearance  of  patient  019092  from
family F8.
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1543Figure 3. A direct sequencing analysis of the coding region of the Usher syndrome type IIA (USH2A) gene. A: Sequence presents the
heterozygous missense mutation c.2802T>G (p.C934W) detected in patient 077006. B: Sequence shows the heterozygous missense mutation
c.8232G>C (p.W2744C) identified in patient 077006. C: Sequence presents the heterozygous nonsense mutation c.1876C>T (p.R626X)
identified in patient 073001. D: Sequence shows the heterozygous nonsense mutation c.3788G>A (p.W1263X) detected in patient 019082.
E shows the heterozygous, one-base-deletion mutation c.6249delT (p. I2084fs) in patient 073001; F is the corresponding wild-type sequence.
G presents a heterozygous 7 bp deletion mutation c.9492_9498del TGATGAT (p. D3165fs) in patient 019082; H shows the corresponding
wild-type sequence. I presents the heterozygous, one-base-deletion mutation c.7123delG (p. G2375fs) in patient 019092; J shows the
corresponding wild-type sequence. K: Sequence shows the heterozygous nonsense mutation c.14403C>G (p. Y4801X) detected in patient
019092.
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1544were designed to obtain the best HRM performance, avoiding
hairpin and primer–dimer formation as much as possible, and
keeping the amplicon length under 250 base pairs. One pair
of specific primers was designed for detecting a mutation in
exon 32 (Table 2). The 10 μl reaction mixture consisted of
5  μl  SsoFast  EvaGreen  Supermix  (Bio-Rad  Laboratories,
Hercules, CA), 1 μl genomic DNA (10–150 ng/μl), 0.5 μl
forward primer (10 pmol/μl), 0.5 μl reverse primer (10 pmol/
μl), and 3 μl double distilled water. PCR cycling and an HRM
analysis were performed on the Rotor-Gene 6000TM (Corbett
Research, Mortlake, NSW, Australia) [22].
Bioinformatics  analysis:  Garnier-Osguthorpe-Robson
(GOR) software was used to predict the effect of the mutation
on the secondary structure of USH2A [23]. This method infers
the  secondary  structure  of  a  sequence  by  calculating  the
probability for each of the four structure classes (helix, sheet,
turn, and loop), based on the central residue and its neighbors
from the calculated matrices [23].
RESULTS
Clinical findings: This study identified one Chinese family,
consisting  of  four  patients  and  one  unaffected  relative,
diagnosed  with  non-syndromic  RP,  and  three  unrelated
Chinese families, including four patients and six unaffected
relatives diagnosed with USH2. The inheritance pattern in the
families was autosomal recessive (Figure 1). All the patients
had  experienced  night  blindness  and  vision  acuity
impairment. The patients with USH2 had hearing impairment
in  early  childhood.  Ophthalmoscopic  examination
demonstrated attenuation of the retinal vessels, bone-spicule
pigmentation in the fundus, and waxy pallor of the optic nerve
head (Figure 2). The wave amplitudes of the ERG of the
probands  were  indistinguishable  from  the  baseline.
Audiometric tests indicated moderate to severe sensorineural
hearing impairment in the patients with USH2; in contrast, the
results  from  the  patients  with  non-syndromic  arRP  were
normal. Vestibular functions of all the patients were normal.
The detailed clinical information for each family’s proband is
summarized in Table 3.
Genotyping  results:  Family  FR1  was  genotyped  with  50
polymorphic  markers  around  the  known  arRP  loci.  The
mapping results excluded the other known arRP loci with the
exception of the USH2A. Further genotyping and haplotyping
analysis  for  the  six  markers  (D1S237,  D1S419,  D1S556,
D1S229, D1S227, and D1S2860) suggested that the USH2A
Figure 4. A restriction fragment length analysis of the four mutations detected in this study. A: c.2802T>G abolished a HincII restriction site
that co-segregated with the affected individuals and the carriers (42 bp, 57 bp, 99 bp, 717 bp, and 774 bp), but not with unaffected individuals
and normal controls (42 bp, 57 bp, and 717 bp). B: c.8232G>C created a new HpyCH4V restriction site that co-segregated with the affected
individuals and the carriers (88 bp, 186 bp, 218 bp, and 274 bp), but not with unaffected individuals and normal controls (218 bp, 274 bp).
C: c.3788G>A abolished a BsaI restriction site that co-segregated with the affected individuals and the carriers (70 bp, 132 bp, 422 bp, and
492 bp), but not with unaffected individuals and normal controls (70 bp, 132 bp, and 422 bp). D: c.14403C>G created a SpeI restriction site
that co-segregated with the affected individuals and the carriers (145 bp, 300 bp, and 445 bp), but not with unaffected individuals and normal
controls (445 bp). A participant identification number is given above each lane. N represents normal controls.
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1545gene might be the disease-causing gene in this family (Figure
1).
Mutation analysis: Sequencing of the USH2A gene revealed
17  sequence  variants  in  this  study,  eight  of  which  were
pathogenic  mutations  (Table  4).  All  eight  pathogenic
mutations  were  heterozygous;  seven  of  them  were  first
detected in the current study (Figure 3 and Table 4). Using
RFLP,  SSCP,  or  HRM  analysis,  the  eight  mutations  co-
segregated  with  the  RP/USH2  phenotype,  respectively
(Figure 4, Figure 5, Figure 6). Analyses did not detect the other
seven mutations in the 100 normal controls, with the exception
of p.C934W, which was identified in its heterozygous state in
two individuals among the 100 normal controls (Table 4).
Four different combinations of heterozygous mutations
were  detected  in  the  four  families.  In  family  FR1  (non-
syndromic  arRP),  two  missense  mutations,  c.2802T>G
(p.C934W) and c.8232G>C (p.W2744C), were detected in
different alleles of patient 077006 (Figure 1, Figure 3, Figure
4). Using the GOR method, the results for secondary structure
prediction suggested that p.C934W replaced two β sheets “E”
with two coils “C” at amino acids 935 and 940, respectively.
Mutation p.W2744C substituted a β sheet “E” and two turn
sheets “T” for three coils “C” at amino acid 2745, 2747, and
2748, respectively (Figure 7). For the three USH2 families
(F6, F7, and F8), one allele carried nonsense mutations, c.
1876C>T  (p.R626X),  c.3788G>A  (p.W1263X),  and  c.
Figure 5. A single-strand, conformation, polymorphism analysis and a 16% denaturing polyacrylamide gel electrophorese analysis. A: Single
strand conformation polymorphism (SSCP) analysis for the heterozygous mutation c. 1876C>T revealed that the mutant pattern (four bands)
co-segregated with the affected individuals and carriers, but not with the unaffected individuals and normal controls (three bands). B: SSCP
analysis for c.7123delG showed that the mutant pattern (three bands) co-segregated with the affected individuals and carriers, but not with
the  unaffected  individuals  and  normal  controls  (two  bands).  C:  16%  denaturing  polyacrylamide  gel  electrophorese  analysis  for  the
heterozygous mutation c.9472_9498delTGATGAG (p. D3165fs) revealed that the mutant pattern (two bands) co-segregated with the affected
individuals, but not with the unaffected individuals and normal controls (one band). Participant identification numbers are listed above each
lane and N represents the normal controls.
Figure 6. A high-resolution, melt curve
analysis  (HRM)  for  the  mutation  c.
6249delT (p. I2084fs) in family F6. In
the  amplicon,  there  is  a  SNP
rs6657250,  c.6317T>C,  as  marked  in
the plot. A: A difference plot for the five
members  in  family  F6.  The  median
green, straight line presents the normal
control with c.6317T>C. The real-time
PCR products of the family members are
compared to the median normal control
to produce the plot. The curve revealed
that the mutant pattern (area within the
rectangle)  co-segregated  with  the
affected  individuals  073001,  073004,
and carriers, 073003, but not with the
unaffected individuals 073002, 073005,
and  normal  controls  c.6317T/T  or  c.
6317C/C. B: Direct sequencing analysis
shows  the  heterozygous,  one-base-
deletion  mutation  c.6249delT
(p.I2084fs)  in  patients  073001  and
073004  and  in  the  carrier  073003;
sequences  in  individuals  073002  and
073005 are the wild type.
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154614403C>G (p. Y4801X), respectively, while the other allele
harbored  deletion  mutations  c.6249delT  (p.  I2084fs),  c.
9492_9498del TGATGAT (p. D3165fs), and c.7123delG (p.
G2375fs), respectively (Figure 1, Figure 3, Figure 4, Figure
5, Figure 6).
In addition to the eight pathogenic mutations detected in
this study, nine nonpathogenic sequence variants were also
identified. Table 5 summarizes these variants based on their
nature and frequency.
DISCUSSION
This study detected eight different mutations of the USH2A
gene isoform b in one non-syndromic arRP family and in three
USH2  families.  Scandinavian,  French,  European,  and
Canadian studies [12,14,16,24-26] previously reported the
nonsense mutation p.R626X. The remaining seven mutations
were first identified in this study.
Rivolta et al. first reported that about 4.5% of 225 patients
from North America with non-syndromic recessive RP carried
the missense mutation p.C759F [12]. Then, Bernal et al. found
Figure 7. The effect of p.C934W and p. W2744C on the secondary structure of the USH2A using the GOR method. W denotes wild type, M
denotes mutant.
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1548that  there  was  a  similar  detecting  frequency  (4.6%)  for
p.C759F  in  Spanish  patients  [13].Two  novel  missense
mutations, p.C934W and p.W2744C, were found in family
FR1. Although p.C934W was identified (in a heterozygous
state) in two individuals among the 100 normal controls, both
mutations have been classified as deleterious-effect missense
mutations with several lines of evidence. Both mutations co-
segregated  with  the  phenotype  of  family  FR1  and  both
residues (C934 and W2744), located in the 8th Lam EGF
domains  and  in  the  14th  FN3  repeat  of  the  usherin,
respectively,  were  highly  conserved  in  different  species
(Figure 8). The results of GOR suggested that p.C934W and
p.W2744C  lead  to  secondary  structure  changes  around
residues 934 and 2744, which might interfere with the correct
folding of the usherin (Figure 7). As the results of audiometric
tests for the patients from family FR1 were normal, the two
compound missense mutations might be responsible for RP
without hearing loss.
Three different compound heterozygous mutations were
identified in three families (F6, F7, and F8) with USH2 and
all six mutations directly or indirectly resulted in premature
termination of the USH2A translation. This is consistent with
Dreyer et al. [25] previous observation that patients carrying
compound heterozygous mutations (either two truncating or
one truncating combined with one missense) in exon 22–72
presented  the  Usher  type  II  phenotype.  In  contrast  to  the
patients from the three USH2 families, the patients in FR1
carried two missense mutations. A recent study in a cohort of
272 Spanish patients with non-syndromic RP resulted in the
identification of two mutant alleles of the USH2A gene in nine
patients,  with  seven  of  them  carrying  either  homozygous
missense mutations or two heterozygous missense mutations
[18]. In a large Chinese family, four patients carrying one
truncating combined with one missense mutation (p.G1734R)
exhibited  RP  with  hearing  loss,  while  the  only  person
harboring  the  homozygous  misense  mutation  (p.G1734R)
presented  RP  without  hearing  loss  [19].  However,  this
phenomenon was not observed in one Israeli family with three
non-syndromic RP patients carrying one missense mutation
and one truncating mutation [15].
As in our previous study [21], with the exception of one
mutation (p.R626X), the other mutations identified in the
current study were novel and were spread relatively evenly
along the USH2A gene (Figure 9). These results indicate that
the mutation spectrum for the USH2A gene among Chinese or
Asian patients differs from the mutation spectrum among
European Caucasians. The common mutations, p. E767fs for
USH2 and p.C759F for arRP in Caucasians, are not detected
in Chinese and Japanese patients [12-14,16,18,19,21,27-29].
In  conclusion,  our  results  further  support  previous
indications that the mutations of the USH2A gene are also
responsible for non-syndromic RP in Chinese patients. The
Figure 8. The sequence alignment portion of A: Laminin epidermal growth factor (EGF)-like domain and B: Fibronectin type 3 domain, in
the long usherin isoform from different species. Both Cys934 (C934) and Trp2744 (W2744) are conserved during evolution. The arrows
indicate the mutated residues in Usher syndrome type IIA (USH2A).
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1549mutation spectrum among Chinese patients appears to differ
from that among European Caucasians.
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